The big news in US equities markets today is the potential, massive merger in the pharmaceutical industry
Jay Soloff
Argonath Financial
The big news in US equities markets today is the potential, massive merger in the pharmaceutical industry. Valeant Pharmaceuticals (VRX) is offering to buy Allergan (AGN) for a cash-and-stock deal worth just under $46 billion. Valeant is a generic drug company that's been on a buying spree as it moves into specialty medicine. Allergan is known mostly for Botox injections - a $2 billion business last year and rapidly growing. The most noteworthy part of this deal is the involvement of hedge fund manager Bill Ackman and his Pershing Square fund. Ackman had covertly bought up 4.99% of AGN's shares before partnering with Valeant to pursue a hostile takeover. Ackman now owns 9.7% of AGN's outstanding stock. It appears investors (and analysts) believe this is a good deal for both companies with AGN up 16% and VRX up 7% as of this writing. (VIEW LINK)
Never miss an update
Enjoy this wire? Hit the ‘like’ button to let us know.
Stay up to date with my current content by
following me below and you’ll be notified every time I post a wire
I'm an investments analyst for a US-based independent investment research firm. My focus is on economics, options, and all types of stocks, but especially tech, Internet, and renewable energy companies. I have experience as a options market maker on the floor of the CBOE, as a consultant on Wall Street, and as a senior analyst at a multi-strategy hedge fund. You can visit my website at www.argonathfinancial.com.
2 topics
Jay Soloff
Research Analyst
Argonath Financial
I'm an investments analyst for a US-based independent investment research firm. My focus is on economics, options, and all types of stocks, but especially tech, Internet, and renewable energy companies. I have experience as a options market...
Expertise
No areas of expertise
Jay Soloff
Research Analyst
Argonath Financial
I'm an investments analyst for a US-based independent investment research firm. My focus is on economics, options, and all types of stocks, but especially tech, Internet, and renewable energy companies. I have experience as a options market...
Expertise
No areas of expertise
Comments
Comments
Sign In or Join Free to comment
most popular
Equities
This recently triggered market signal has never failed to predict gains
Ophir Asset Management